financetom
Business
financetom
/
Business
/
Gatos Silver Up Near 1% In US After-Hours Trading as it Reports Overall Q1 Earnings Increase, But LGJV Net Income Drops
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Gatos Silver Up Near 1% In US After-Hours Trading as it Reports Overall Q1 Earnings Increase, But LGJV Net Income Drops
May 6, 2024 2:07 PM

04:50 PM EDT, 05/06/2024 (MT Newswires) -- Gatos Silver ( GATO ) was up near 1% in US after-hours trading on Monday as it reported an increase in its overall first-quarter profit, but in a drop in net income for the Los Gatos Joint Venture over the same period.

It had overall first quarter net income of US$2.5 million, or US$0.04 per share, in the quarter, up 203% from US$0.8 million, or US$0.01, a year earlier..

Among other overall highlights, Gatos cited EBITDA of US$1.8 million, up 107% from US$0.9 million; cash flow provided by operating activities of US$15.1 million, compared to cash flow used by operating activities of US$4.1 million; and free cash flow of US$15.1 million, up from a deficit of US$4.1 million

The company has a 70% interest in the Los Gatos Joint Venture (LGJV), which in turn owns the Cerro Los Gatos mine in Mexico. Production for the first quarter of 2024 was previously disclosed on April 9, 2024. Today it reported LGJV Q1 2024 results that included net income of US$10.2 million, down 20% from US$12.7 million

"During the first quarter we continued to add cash to the balance sheet mainly because of the previously disclosed strong operational performance at the LGJV. All-in sustaining cost per silver ounce was at the lower end of 2024 guidance thanks to improved operating efficiencies, which helped to offset inflationary cost pressures and the impact of the stronger Mexican peso," Chief executive Dale Andres said in a statement

Andres added: "We now expect full year 2024 silver and silver equivalent production to be in the top half and AISC to be in the lower half of our previously announced guidance ranges. We also continue to advance our growth initiatives. Conversion drilling of the South-East Deeps inferred resource to extend mine life progressed well during the quarter and the LGJV has started ramping-up exploration efforts on near-mine and other targets in the highly prospective Los Gatos district."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Russian court fines Apple for not deleting two podcasts, RIA reports
Russian court fines Apple for not deleting two podcasts, RIA reports
Nov 5, 2024
MOSCOW, Nov 5 (Reuters) - A Moscow court on Tuesday fined U.S. technology giant Apple ( AAPL ) 3.6 million roubles ($36,889) for refusing to remove two podcasts that contained information aimed at destabilising the political situation in Russia, the RIA news agency reported. Russia has fined several foreign companies for not removing content in the past few years in...
Endeavour Silver Swings to Q3 Profit, Revenue Rises
Endeavour Silver Swings to Q3 Profit, Revenue Rises
Nov 5, 2024
09:30 AM EST, 11/05/2024 (MT Newswires) -- Endeavour Silver ( EXK ) reported Q3 adjusted net earnings Tuesday of $0.01 per share, swinging from a loss of $0.04 a year earlier. Two analysts polled by Capital IQ expected a breakeven figure. Revenue for the quarter ended Sept. 30 was $53.4 million, up from $49.5 million a year earlier. Two analysts...
Hims & Hers Health to Offer Generic Diabetes Drug in 2025
Hims & Hers Health to Offer Generic Diabetes Drug in 2025
Nov 5, 2024
07:37 AM EST, 11/05/2024 (MT Newswires) -- Hims & Hers Health ( HIMS ) said Monday in a letter to shareholders it plans to launch diabetes drug Liraglutide on its platform in 2025. The company said it has already confirmed a core supplier for the drug, which is a generic version of Novo Nordisk's (NVO) type-2 diabetes treatment Victoza, and...
AdaptHealth Swings to Q3 Earnings, Revenue Increases; Fiscal 2024 Revenue Guidance Lowered
AdaptHealth Swings to Q3 Earnings, Revenue Increases; Fiscal 2024 Revenue Guidance Lowered
Nov 5, 2024
09:29 AM EST, 11/05/2024 (MT Newswires) -- AdaptHealth ( AHCO ) reported Q3 earnings Tuesday of 40.15 per diluted share, compared with a loss of $3.43 per share a year earlier. Analysts polled by Capital IQ expected earnings of $0.17 per share. Net revenue for the quarter ended Sept. 30 was $805.9 million, up from $804 million a year earlier....
Copyright 2023-2026 - www.financetom.com All Rights Reserved